22/12/2021 - Institutional news
From 2022, the World Anti-Doping Agency's (WADA) list of prohibited substances and methods in sport is to include important changes regarding the use of glucocorticoids in sport. From this point on, all injectable methods will be prohibited during competitions, in addition to oral and rectal administration. Other ways of receiving the medication, such as via inhalation, intranasal or dermatological routes, will continue to be permitted if their use is necessary for therapeutic reasons. There will still be no restrictions on the use of glucocorticoids in out-of-competition periods. Criteria have also been defined to improve the safety of glucocorticoid administration for therapeutic reasons. Firstly, the distinction between prohibited and permitted routes of administration has been improved by defining a specific information concentration for each glucocorticoid. Secondly, blanking periods after prohibited treatments have been defined so that those performed in out-of-competition periods close to competitions do not lead to false positive results in samples collected during competitions.
22/12/2021 - Institutional news
The Director of the Addictions Process at INAD and researcher at the Hospital del Mar Medical Research Institute becomes a member of the executive committee of this organization that promotes knowledge and research on dual pathology. The congress of the World Association on Dual Disorders (WADD) approved at its congress, held in Paris between December 7 and 9, the incorporation of Dr. Marta Torrens to its executive committee. Thus, the Director of the Addictions Process of the Institute of Neuropsychiatry and Addictions of the Hospital del Mar (INAD) and coordinator of the Addictions Research Group of the Hospital del Mar Medical Research Institute (IMIM), will participate in the organization's decision-making, such as the organization of congresses, training courses and publications.
03/12/2021 - Institutional news
The Hospital del Mar Medical Research Institute (IMIM) has signed a five-year contract with the World Anti-Doping Agency (WADA, https://www.wada-ama.org/ ), within the framework of a tender of offers at an international level, worth € 1,880,000, for the preparation of reference materials for its external quality assessment program of laboratories (EQAS) accredited to carry out anti-doping control around the world (WADA's External Quality Assessment Scheme). Dr. Oscar Pozo, group leader of the Applied Metabolomics Research Group of the Neurosciences Research Program at IMIM, will be responsible for the execution of the contract as of January 2022.
29/11/2021 - Institutional news
The Emeritus Head of the Surgery Department at Hospital del Mar and researcher at the Hospital del Mar Institute of Medical Research became a full member of the RAMC, in a ceremony held on 29 November at the institution's headquarters. Dr. Lluís Grande is now a full member of the Royal Academy of Medicine of Catalonia. The appointment was made on 29 November, in a ceremony held at the institution's headquarters, in which the Emeritus Head of the Surgery Department at Hospital del Mar and researcher at the Hospital del Mar Institute of Medical Research (IMIM), delivered the speech, "Showing the data: a recipe for improving quality in an academic surgery department." The response was given by Dr. Laureà Fernández-Cruz, also a full member of the RAMC.
25/11/2021 - Institutional news
The emeritus head of both the Pneumology Service at Hospital del Mar and the Myogenesis, Inflammation and Muscle Function research group at the Hospital del Mar Medical Research Institute is one of the fourteen experts invited to participate. Dr. Joaquim Gea, emeritus head of both the Pneumology service at Hospital del Mar and the Myogenesis, Inflammation and Muscle Function research group at the Hospital del Mar Medical Research Institute (IMM), was one of the two international experts, and the only European, invited to participate in the drafting of the consensus document for the Colombian Association of Pneumology and Thoracic Surgery, on the follow-up and treatment of patients who have overcome COVID-19.
17/11/2021 - Institutional news
Stanford University has recently published an update of the list of the top 2% most widely cited scientists in different disciplines, the World's Top 2% Scientists. This ranking, considered the most prestigious worldwide, is based on the bibliometric information contained in the Scopus database and includes more than 180,000 researchers from the more than 8 million scientists considered to be active worldwide, with 22 scientific fields and 176 subfields taken into account. Of the dozen researchers from the IMIM and Hospital del Mar who appear on the list, special mention should be made of Dr. Jordi Mestres, coordinator of the GRIB (IMIM/UPF) systems pharmacology research group, who is ranked number 1 in Catalonia, number 5 in Spain and 263rd in the world in the Medicinal and Biomolecular Chemistry subfield out of the 88,725 researchers in this area. The research carried out by Dr. Mestres is at the interface between chemistry and biology, where the current focus is on the development of biocheminformatics tools and databases, the topographic analysis of molecular surfaces and the design of protocols for virtual screening.
10/11/2021 - Institutional news
Five groups led by IMIM and Hospital del Mar professionals have been accepted as part of the new RICORS research networks. These Redes de Investigación Cooperativa Orientadas a Resultados en Salud, or Networks of Cooperative Research oriented to Health Results in English, are decided by the Instituto de Salud Carlos III and include funding, which in this case will be over €1.1 million. One of these groups will actually coordinate one of the RICORS networks. The aim of these new bodies is to promote research oriented towards health results by coordinating the research activity within the Spanish National Health System around a defined and focused research objective that is specifically useful for the general public, as well as structuring R&D&I in research groups from different Autonomous Communities, guiding their research activity towards common goals that enable results to be achieved which can then be transferred to the Spanish populace.
The Catalan Society of Infectious Diseases and Clinical Microbiology (SCMIMC) has awarded one of its pre-doctoral grants to Dr. Elena Sendra, a consultant in Hospital del Mar's Infectious Diseases Service. This is a biannual grant that will allow her to develop her doctoral thesis project. The grant was awarded during the XXX Meeting of the society, held on 15th and 16th October in Sitges, Garraf.
13/10/2021 - Institutional news
The Hospital del Mar Medical Research Institute is once again holding its annual meeting to update on the progress made and to highlight the talent of its researchers. After a year and a half marked by the Covid-19 pandemic, the Hospital del Mar Medical Research Institute (IMIM) has recovered its Scientific Retreat, the first face-to-face event since the outbreak of SARS-CoV-2. A new opportunity "to learn about the latest advances made by the institution's research groups, share experiences and seek new avenues for collaboration", as explained during the opening ceremony by the director of IMIM, Dr. Joaquín Arribas. The day got underway with an exceptional round table. Dr. Josep Tabernero, director of the Vall d'Hebron Institute of Oncology (VHIO) and head of the Medical Oncology Service of the Vall d'Hebron University Hospital, and Dr. Eduard Batlle, ICREA researcher at the Barcelona Institute for Research in Biomedicine (IRB), former IMIM researcher and current King Jaime I award winner, analyzed translational research, in a debate moderated by Dr. Jordi Camí, director of the Barcelona Biomedical Research Park (PRBB).
Més informació "The IMIM Scientific Retreat, an opportunity to promote research"
08/10/2021 - Institutional news
The IMIM Foundation announces one open position for a Recognised Researcher (R4) with the objective of incorporating an international leader researcher to one of the main research areas of IMIM: Cancer, Epidemiology and Public Health, Clinical Translation, Biomedical Informatics, or Neurosciences. Incorporation to the IMIM Foundation will be through a permanent full-time work contract. The mission of the job is to carry out research of excellence and to achieve effective transfer of this to the most important health problems in the population, observing, at all times, the Institute's Code of Good Practice and Code of Ethics.
Servei de Comunicació:
Marta Calsina Freixas(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact